| For: | Assis J, Pereira D, Medeiros R. Ovarian cancer and DNA repair: DNA ligase IV as a potential key. World J Clin Oncol 2013; 4(1): 14-24 [PMID: 23538968 DOI: 10.5306/wjco.v4.i1.14] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v4/i1/14.htm |
| Number | Citing Articles |
| 1 |
Jessica M. Hearn, George M. Hughes, Isolda Romero-Canelón, Alison F. Munro, Belén Rubio-Ruiz, Zhe Liu, Neil O. Carragher, Peter J. Sadler. Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action. Metallomics 2018; 10(1) doi: 10.1039/C7MT00242D
|
| 2 |
Malek Djeribi, Ichraf Nagazi, Veronica Cocetta, Necmi Dege, Noureddine Issaoui, Lucia Zanetti, Mauro Carraro, Brahim Ayed. Synthesis of novel supramolecular selenomolybdate as anticancer agents: An experimental and DFT computational analysis. Journal of Molecular Structure 2024; 1306 doi: 10.1016/j.molstruc.2024.137880
|
| 3 |
Kristyna Tomasova, Andrea Cumova, Karolina Seborova, Josef Horak, Kamila Koucka, Ludmila Vodickova, Radka Vaclavikova, Pavel Vodicka. DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome. Cancers 2020; 12(7) doi: 10.3390/cancers12071713
|
| 4 |
Soukaina Benkirane, Rachid Haloui, Oussama Moussaoui, Achraf Abdou, Souad ElKhattabi, Saïd El Kazzouli, Houria Misbahi. Exploring pyrimidine Schiff bases as promising dual CDK8 and DNA ligase IV inhibitors: synthesis, characterization, and computational study. Journal of Molecular Liquids 2026; 449 doi: 10.1016/j.molliq.2026.129434
|
| 5 |
Zihan Zhang, Jingyu Zhao, Zhimin Zhang, Zhuoyan Fu, Xinru Li, Ziming Zhu, Qingxin Li, Xuenan Wang, Jinxiang Yuan, Fei Gao, Xiaomei Wang. Insights into Ovarian Cancer: Unraveling the Role of DNA Double-strand Break-related Genes in Pathogenesis and Therapeutic Avenues. Reproductive Sciences 2026; doi: 10.1007/s43032-026-02082-y
|
| 6 |
Annahita Sallmyr, Seema Khattri Bhandari, Tasmin Naila, Alan E. Tomkinson. Mammalian DNA ligases; roles in maintaining genome integrity. Journal of Molecular Biology 2024; 436(1) doi: 10.1016/j.jmb.2023.168276
|
| 7 |
Alina Rosinha, Joana Assis, Francisca Dias, Augusto Nogueira, Deolinda Pereira, Joaquina Maurício, Ana Luísa Teixeira, Rui Medeiros. DNA repair system and renal cell carcinoma prognosis: under the influence of NBS1. Medical Oncology 2015; 32(11) doi: 10.1007/s12032-015-0701-0
|
| 8 |
Jie Liu, Jia Li, Jian-Fang Zhang, Xiao-Yan Xin. Combination of Fenretinide and Selenite Inhibits Proliferation and Induces Apoptosis in Ovarian Cancer Cells. International Journal of Molecular Sciences 2013; 14(11) doi: 10.3390/ijms141121790
|
| 9 |
Sylwia A. Dragulska, Ying Chen, Marek T. Wlodarczyk, Mina Poursharifi, Peter Dottino, Rein V. Ulijn, John A. Martignetti, Aneta J. Mieszawska. Tripeptide-Stabilized Oil-in-Water Nanoemulsion of an Oleic Acids–Platinum(II) Conjugate as an Anticancer Nanomedicine. Bioconjugate Chemistry 2018; 29(8) doi: 10.1021/acs.bioconjchem.8b00409
|
| 10 |
Damla Raimoglou, Murat Cimci, Elif Citak, Selin Unal, Narmina Malikova, Eser Durmaz, Mehmet Guven. Investigation of the association between polymorphisms in DNA repair enzymes and STEMI. Human Gene 2024; 42 doi: 10.1016/j.humgen.2024.201340
|
| 11 |
Nour Al Kafri, Sassan Hafizi. Identification of signalling pathways activated by Tyro3 that promote cell survival, proliferation and invasiveness in human cancer cells. Biochemistry and Biophysics Reports 2021; 28 doi: 10.1016/j.bbrep.2021.101111
|
| 12 |
Valéria Tavares, Ricardo Pinto, Joana Assis, Deolinda Pereira, Rui Medeiros. Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviour. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1873(1) doi: 10.1016/j.bbcan.2019.188331
|
| 13 |
Nahid Punjani, Dolores J. Lamb. Canary in the Coal Mine? Male Infertility as a Marker of Overall Health. Annual Review of Genetics 2020; 54(1) doi: 10.1146/annurev-genet-022020-023434
|
| 14 |
Mary Ellen Gee, Zahra Faraahi, Aiste McCormick, Richard J. Edmondson. DNA damage repair in ovarian cancer: unlocking the heterogeneity. Journal of Ovarian Research 2018; 11(1) doi: 10.1186/s13048-018-0424-x
|
| 15 |
Hisanaga Nomura, Daiki Tsuji, Shohei Ueno, Takashi Kojima, Satoshi Fujii, Tomonori Yano, Hiroyuki Daiko, Ken Demachi, Kunihiko Itoh, Toshikatsu Kawasaki. Relevance of pharmacogenetic polymorphisms with response to docetaxel, cisplatin, and 5-fluorouracil chemotherapy in esophageal cancer. Investigational New Drugs 2022; 40(2) doi: 10.1007/s10637-021-01199-y
|
| 16 |
Sathya Neelature Sriramareddy, Majeed Jamakhani, Léa Vilanova, Hélène Brossel, Bernard Staumont, Malik Hamaidia. Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1323313
|
| 17 |
Özlem Kaplan, Nazan Gökşen Tosun. Molecular pathway of anticancer effect of next-generation HSP90 inhibitors XL-888 and Debio0932 in neuroblastoma cell line. Medical Oncology 2024; 41(8) doi: 10.1007/s12032-024-02428-z
|
| 18 |
Joana Assis, Deolinda Pereira, Augusto Nogueira, Rui Medeiros. Ovarian Cancer - From Pathogenesis to Treatment. 2018; doi: 10.5772/intechopen.73863
|
| 19 |
Joana Assis, Carina Pereira, Augusto Nogueira, Deolinda Pereira, Rafael Carreira, Rui Medeiros. Genetic variants as ovarian cancer first-line treatment hallmarks: A systematic review and meta-analysis. Cancer Treatment Reviews 2017; 61 doi: 10.1016/j.ctrv.2017.10.001
|
| 20 |
Harshavardhani Canchi Sistla, Arun Seshachalam, Krishna Kumar Rathnam, Taruna Rajagopal, Srikanth Talluri, Subaranjana Saravanaguru Vasanthi, Nageswara Rao Dunna. Integrated case–control and in silico analysis of DNA double-strand break repair gene variants (RAD51, XRCC2, XRCC3, XRCC4, and LIG4) for ovarian cancer susceptibility. Gene 2026; 983 doi: 10.1016/j.gene.2025.149989
|
| 21 |
Zhenzhen Wu, Yuming Wang. Studies of lncRNAs in DNA double strand break repair: what is new?. Oncotarget 2017; 8(60) doi: 10.18632/oncotarget.22090
|
| 22 |
Sonali Verma, Gresh Chander, Ruchi Shah, Rakesh Kumar. BRCA1 and BRCA2 Mutations - Diagnostic and Therapeutic Implications. 2023; doi: 10.5772/intechopen.108431
|